Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraPancreasWhole-Body IrradiationTransplantation, AutologousTransplantation ConditioningSurvival AnalysisAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationBone and BonesGraft RejectionTransplantation, IsogeneicLiver TransplantationRadiation ChimeraGraft Enhancement, ImmunologicTransplantation ToleranceHematopoietic Stem CellsKidney TransplantationImmunosuppressive AgentsMice, Inbred C57BLLeukocyte TransfusionBusulfanBone Marrow PurgingRecurrenceSkin TransplantationImmunosuppressionHLA AntigensTransplantation ImmunologyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionTreatment OutcomeChimerismActuarial AnalysisHeart TransplantationTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideBone Marrow DiseasesPancreas TransplantationT-LymphocytesAcute DiseaseHematopoiesisCombined Modality TherapyLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte Culture Test, MixedHematologic NeoplasmsRemission InductionChimeraHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsMice, Inbred BALB CLeukemia, MyeloidStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalRetrospective StudiesSevere Combined ImmunodeficiencyColony-Forming Units AssayMyelodysplastic SyndromesLung TransplantationCyclosporineHematologic DiseasesBlood DonorsBone DensityMice, Inbred C3HImmune ToleranceOrgan TransplantationCell DifferentiationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryFollow-Up StudiesCarmustineGraft vs Tumor EffectSurvival RatePancytopeniaCytomegalovirus InfectionsSpleenLeukocyte CountGraft vs Leukemia EffectCytarabineGranulocyte Colony-Stimulating FactorBone ResorptionMelphalanCells, CulturedEtoposide